In vitro stimulation of insulin release by SL 84.0418, a new α2-adrenoceptor antagonist
- 1 March 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 254 (1-2), 27-33
- https://doi.org/10.1016/0014-2999(94)90366-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- In vivo pharmacological profile of SL 84.0418, a new selective, peripherally active α2-adrenoceptor antagonistEuropean Journal of Pharmacology, 1993
- Stimulation of insulin secretion by the imidazoline α2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding siteEuropean Journal of Pharmacology, 1993
- The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cellsEuropean Journal of Pharmacology, 1991
- Block of ATP‐regulated potassium channels by phentolamine and other α‐adrenoceptor antagonistsBritish Journal of Pharmacology, 1991
- Mechanisms involved in stimulation of insulin secretion by the hypoglycaemic alpha-adrenergic antagonist, DG-5128Biochemical and Biophysical Research Communications, 1991
- Effects of putative activators of K+ channels in mouse pancreatic β‐cellsBritish Journal of Pharmacology, 1989
- Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic β-cellsBritish Journal of Pharmacology, 1988
- Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretionDiabetologia, 1986
- Studies on RX 781094: a selective, potent and specific antagonist of α2‐adrenoceptorsBritish Journal of Pharmacology, 1983
- Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK miceDiabetologia, 1981